RS51138B - S-mirtazapin za lečenje nastupa vreline (valunga) - Google Patents

S-mirtazapin za lečenje nastupa vreline (valunga)

Info

Publication number
RS51138B
RS51138B RSP-2009/0504A RSP20090504A RS51138B RS 51138 B RS51138 B RS 51138B RS P20090504 A RSP20090504 A RS P20090504A RS 51138 B RS51138 B RS 51138B
Authority
RS
Serbia
Prior art keywords
mirtazapine
treatment
hot flush
hot
flush
Prior art date
Application number
RSP-2009/0504A
Other languages
English (en)
Inventor
Bernardus PEETERS B.W.M.M.
Anton Egbert Peter Adang
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS51138(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of RS51138B publication Critical patent/RS51138B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Čist S-mirtazapin za upotrebu u lečenju nastupa vreline (valunga).Prijava sadrži još 1 zavisni patentni zahtev.
RSP-2009/0504A 2004-11-15 2005-11-14 S-mirtazapin za lečenje nastupa vreline (valunga) RS51138B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15
PCT/EP2005/055947 WO2006051111A1 (en) 2004-11-15 2005-11-14 S-mirtazapine for the treatment of hot flush

Publications (1)

Publication Number Publication Date
RS51138B true RS51138B (sr) 2010-10-31

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2009/0504A RS51138B (sr) 2004-11-15 2005-11-14 S-mirtazapin za lečenje nastupa vreline (valunga)

Country Status (31)

Country Link
US (4) US20070265245A1 (sr)
EP (1) EP1814555B1 (sr)
JP (1) JP2008519810A (sr)
KR (1) KR20070085470A (sr)
CN (2) CN101056641A (sr)
AR (1) AR053780A1 (sr)
AT (1) ATE439843T1 (sr)
AU (1) AU2005303778B2 (sr)
BR (1) BRPI0517818A2 (sr)
CA (1) CA2587283C (sr)
CY (1) CY1110538T1 (sr)
DE (1) DE602005016141D1 (sr)
DK (1) DK1814555T3 (sr)
ES (1) ES2329815T3 (sr)
HK (1) HK1104235A1 (sr)
HR (1) HRP20090513T1 (sr)
IL (1) IL182767A (sr)
MX (1) MX2007005827A (sr)
MY (1) MY144089A (sr)
NO (1) NO20072285L (sr)
NZ (1) NZ554858A (sr)
PE (1) PE20061051A1 (sr)
PL (1) PL1814555T3 (sr)
PT (1) PT1814555E (sr)
RS (1) RS51138B (sr)
RU (1) RU2396957C2 (sr)
SI (1) SI1814555T1 (sr)
TW (1) TW200631584A (sr)
UA (1) UA88655C2 (sr)
WO (1) WO2006051111A1 (sr)
ZA (1) ZA200703884B (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1898919A2 (en) * 2005-06-27 2008-03-19 N.V. Organon A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
JP2009539760A (ja) * 2006-03-06 2009-11-19 ナームローゼ・フエンノートチヤツプ・オルガノン ホルモン枯渇誘発血管運動症状のホルモン療法からの離脱の改良法
AU2007324467A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
US7645750B2 (en) 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
PT3261645T (pt) 2015-02-27 2021-06-17 Dechra Ltd Estimulação do apetite, gestão da perda de peso, e tratamento da anorexia em cães e gatos
MX2019014113A (es) * 2017-05-25 2022-08-18 Glytech Llc Terapia combinada para trastornos neuropsiquiatricos sensibles al antagonista de nmdar.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
DK1067934T3 (da) * 1998-04-02 2004-03-29 Akzo Nobel Nv Flydende oral opløsning omfattende det anti-depressive middel mirtazapin

Also Published As

Publication number Publication date
AU2005303778B2 (en) 2011-02-17
BRPI0517818A2 (pt) 2010-03-16
EP1814555B1 (en) 2009-08-19
ES2329815T3 (es) 2009-12-01
DE602005016141D1 (de) 2009-10-01
CY1110538T1 (el) 2015-04-29
CN101056641A (zh) 2007-10-17
IL182767A (en) 2011-07-31
DK1814555T3 (da) 2009-12-07
US20100267694A1 (en) 2010-10-21
AU2005303778A1 (en) 2006-05-18
UA88655C2 (ru) 2009-11-10
RU2007122391A (ru) 2008-12-20
CA2587283C (en) 2013-01-15
EP1814555A1 (en) 2007-08-08
US20120302552A1 (en) 2012-11-29
RU2396957C2 (ru) 2010-08-20
HRP20090513T1 (en) 2009-10-31
US20130225559A1 (en) 2013-08-29
HK1104235A1 (en) 2008-01-11
IL182767A0 (en) 2007-09-20
WO2006051111A1 (en) 2006-05-18
ZA200703884B (en) 2009-07-29
JP2008519810A (ja) 2008-06-12
SI1814555T1 (sl) 2009-12-31
PL1814555T3 (pl) 2010-01-29
CA2587283A1 (en) 2006-05-18
ATE439843T1 (de) 2009-09-15
TW200631584A (en) 2006-09-16
PT1814555E (pt) 2009-09-30
KR20070085470A (ko) 2007-08-27
PE20061051A1 (es) 2006-10-26
MY144089A (en) 2011-08-15
CN102772414A (zh) 2012-11-14
AR053780A1 (es) 2007-05-23
NO20072285L (no) 2007-06-13
US20070265245A1 (en) 2007-11-15
MX2007005827A (es) 2007-07-20
NZ554858A (en) 2009-10-30

Similar Documents

Publication Publication Date Title
RS51138B (sr) S-mirtazapin za lečenje nastupa vreline (valunga)
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
ATE461217T1 (de) Glp-1-verbindungen
CY1120741T1 (el) Θεραπεια οζωδους σκληρυνσης
TW200612918A (en) Lonidamine analogs
TR200504892A1 (tr) Belirti göstermeyen tüberküloz tedavisi
ECSP088440A (es) Imidazopirazinas como inhibidores de proteinquinasa
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
MX2007002277A (es) Metodos para formar retinoides y usos de los mismos.
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
SE0301650D0 (sv) Novel compounds
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
DK1713438T3 (da) Medicinsk sæbe
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
ITRM20050478A1 (it) Apparato per l'applicazione contemporanea della carbossiterapia e della mesoterapia.
MY140194A (en) Novel fusidic acid derivatives
GB0508988D0 (en) Organic compounds
RS52038B (sr) Upotreba 7-butoksiiminometilkamptotecina za lečenje neoplazmi materice
IS8391A (is) Notkun á síramesíni við meðhöndlun á krabbameini
ATE528561T1 (de) Inline-ventilpatrone
SE0202608D0 (sv) New sequences
UY34598A (es) Antranilamidas insecticidas